Curis Lifesciences (NSE:CURIS) Construction In Progress: ₹13.3 Mil (As of Mar. 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹100.70
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Construction In Progress?

Curis Lifesciences NSE:CURIS 19 Construction In Progress is ₹13.3 Mil as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Curis Lifesciences's quarterly construction in progress increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.2 Mil) and increased from Mar. 2025 (₹0.2 Mil) to Mar. 2026 (₹13.3 Mil).

Curis Lifesciences's annual construction in progress increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.2 Mil) and increased from Mar. 2025 (₹0.2 Mil) to Mar. 2026 (₹13.3 Mil).

Curis Lifesciences Construction In Progress Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Construction In Progress Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Construction In Progress
0.00 0.00 0.15 13.27

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Construction In Progress 0.00 0.00 0.15 13.27
NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹13.3 Mil mean?
Curis Lifesciences (NSE:CURIS) has a Construction In Progress of ₹13.3 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' Construction In Progress too high?
Curis Lifesciences' current Construction In Progress is ₹13.3 Mil. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Construction In Progress compare to ZTS and UTHR?
Curis Lifesciences' Construction In Progress of ₹13.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current Construction In Progress is ₹13.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Construction In Progress of ₹13.3 Mil. The current Construction In Progress is ₹13.3 Mil. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Construction In Progress is ₹13.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹100.70
Price